Healthcare Administrative Automation
H

HendrenAI

HendrenAI builds voice and workflow agents for pharmacies, health systems and pharmaceutical manufacturers. Its agents call payers and PBMs for prior authorization and benefits verification, answer inbound patient calls about refills, scheduling and navigation, run post discharge and chronic care outreach, and enter prescription data, writing structured results back into the pharmacy or hospital system. Pharmacy tools also cover inventory forecasting, diversion monitoring and medication reconciliation.

Routine interactions are handled automatically under an 85/15 model, and exceptions that need clinical judgment go to a pharmacist or clinician. Role based access, configurable guardrails and action histories support that split. Integrations with DRX, which reaches 400 pharmacies, and Liberty Pharmacy Software, which reaches about 3,000 independent pharmacies, are labeled live, and agents deploy into Epic, Oracle Millennium and athenahealth in about four weeks. OncoScope AI runs on the platform.

Founder and CEO John Boos is a pharmacist with an MBA, and the company works from an office in Montvale, New Jersey, with a team drawn from NYU Langone, Mount Sinai and Goldman Sachs. Pharmacy voice handling is priced as low as $0.10 per minute, while platform and implementation charges are quoted. A top ten US hospital is listed as a deal in negotiation.

AI Health Index verifiedNovember 19, 2026
Compare HendrenAI with other vendors
Founded
—
Headquarters
Montvale, New Jersey, United States
Website
hendren.ai
Categories
healthcare-admin-automation, patient-facing-voice-agents, rcm-and-prior-auth
Indexed Products
Hendren Intelligence Platform, Pharmacy Intelligence Platform, Voice AI, Prior authorization automation, Prescription data entry
Buyer Segments
Independent pharmacies, Retail and specialty pharmacies, Health systems, Pharmaceutical manufacturers
Assessment

Capability Axes

An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read

AI Capability
BB on AI CentralityThe model is the engine of a core module. The platform carries other value, but this capability does not exist without it.
Vendor Published

Conversational language processing and agent workflows carry the pharmacy offering. Voice agents interpret inbound and outbound calls, extract details and turn conversations into structured actions around refills, benefits and prior authorization, and LLM driven agents with tool calling carry out those steps in connected systems. Prescription entry and forecasting take the product beyond a telephone interface.

Integration, workflow configuration, access control and operational routing carry value apart from any particular model, and the split between model output and configured logic in each workflow is not broken out. The calls, extraction and writeback that define the product still depend on the learned components.

BB on Autonomy and Oversight ModelThe oversight structure is described and one part is missing, commonly the threshold at which the system stops or what happens after it is wrong.
Vendor Published

Routine, repeatable interactions follow the 85/15 model, with about 85% handled automatically and exceptions such as unusual denials or decisions needing clinical judgment sent to a pharmacist or clinician. Configurable guardrails limit agent behavior, action histories support review, and the acceptable use policy places review and validation duties on qualified users.

Those are identifiable points of intervention rather than a bare claim of human oversight. The split does not set confidence cutoffs, an override procedure for every action or what happens when no reviewer responds, and the promise of no missed calls covers availability rather than correct clinical output.

CC on Model and Technology TransparencyThe architecture is described in general terms with nothing identified. Proprietary is asserted rather than explained.
Vendor Published

The offering uses conversational AI, natural language processing and LLM driven agents to extract information and carry out workflow steps. The company's engineering roles are built around retrieval augmented generation, tool calling, LangChain, LangGraph, Azure OpenAI and AWS Bedrock, which describes the stack the team works on.

That gives a technical direction without fixing the model that serves a production pharmacy call. No release identifier, training dataset, update history or model change notice for customers is given, and a role requirement describes work to build or maintain a system rather than confirming that every listed technology sits in the delivered configuration.

CC on Model Supply Chain DisclosureThe architecture is described and no model provider is named. Naming a hosting provider alone does not lift a record out of this band. Record the host in the note, because it matters for residency and breach scope, and grade on the model layer, which is the question this axis is named for.
Vendor Published

Voice conversations, prescription information and payer responses pass through the agent layer before structured results reach the pharmacy or record system, and outbound calls carry patient details to payer and PBM representatives. The production language model and speech service providers are not listed in any product subprocessor register.

Engineering roles center on Azure OpenAI and AWS Bedrock, and IBM appears as a partner logo, but neither maps current patient data to a supplier and contract. The architecture is recognizable without a complete processing chain, so supplier retention, training rights, transcription services and the conditions for switching model providers sit outside the available service terms.

DD on Clinical and Operational EvidenceNo named deployment and no performance claim a reader can check. A figure published with no source sits here rather than higher.
Vendor Published

The impact figures are projections. A 200% projected ROI for health systems, $89B in potential labor savings across US health systems and 11 billion hours returned to patient care describe the market rather than measured customer results, and the pharmacy calculator estimates savings by comparing call hours and labor cost with the advertised voice rate.

The 85% automation figure has no named deployment, observation window or denominator. The top ten hospital is listed as a negotiation, the DRX and Liberty counts describe pharmacies those systems reach rather than customers, and engineering roles still describe work toward an MVP and first production customers. No evaluation reports completion rates, error rates or clinical benefit for the current agents.

CC on AI Safety and PHI StewardshipGeneral assurances of privacy and security that do not answer the questions artificial intelligence raises: what is retained, what reaches a model, and what happens to it there.
Vendor Published

Role based access, configurable guardrails and action histories control how agents act in healthcare workflows. The acceptable use policy requires an express written agreement before sensitive information is processed and leaves authorizations and consent with the customer, and engineering work runs on synthetic test data or data stripped of identifiers.

The October 2024 privacy notice covers the website only. It does not say how long patient audio, transcripts, prompts or outputs stay in the agent platform, whether they can train models or how deletion reaches suppliers, and no AI safety incident process is described. Test data practices say nothing about production conversations and prescriptions.

Regulatory and Compliance
CC on HIPAA and BAA PostureA status is stated but not supported: compliance is claimed, or business associate status stated, without the underlying document, including where the only privacy notice published covers the website rather than the service that handles patients. The mirror case grades here as well: a substantive privacy document that reaches the service, with no statement of business associate status anywhere and no scope position taken. One of the two elements the band above asks for is present, which is a grade below it and not a grade at the floor.
Vendor Published

HIPAA and HITECH compliance are claimed across agent deployments, and sensitive data use requires a written agreement under the acceptable use policy. Role restrictions and audit trails support that posture in operation, and the platform lists HIPAA, HITECH and SOC 2 together as its compliance basis.

The privacy notice defines its covered service as the website and focuses on visitor and account information, so it does not govern prescription records or patient conversations the agents process. No business associate agreement, subcontractor terms or product scope can be read before contracting, which leaves the compliance claim clearer than the agreement that would govern real patient information.

BB on Security Certifications and Trust CenterA recognized certification is named in the vendor own material without the artifact, or with a scope or renewal question the buyer has to raise. A recognized certification here is an audit of how the vendor operates security, such as SOC 2, HITRUST or ISO/IEC 27001. A certification has a scope and a clock, and both are part of this grade. A certification the vendor attaches to its data center, hosting facility or cloud provider, rather than presenting as its own, is the host's and does not count here.
Vendor Published

The platform claims SOC 2 certification alongside HIPAA, HITECH, role based access control and complete action trails. The SOC 2 claim attaches to HendrenAI's own platform rather than only to a hosting provider, which makes it an operational assurance claim for the company itself.

The report type, examination period, auditor, covered systems and the report itself are not supplied, and the HIPAA and HITECH language covers separate obligations. The framework is named, while its current scope across voice agents, integration services, customer deployments and a distributed engineering team is not set out.

CC on FDA and Regulatory StatusNo device claim is made and the product is scoped accordingly. Most administrative and operational products sit here and are not penalized for it, because this axis grades the appropriateness of the positioning rather than possession of a clearance. A stated limit on use, such as research use only or a clause that the product gives no medical advice, beside marketing that sells the product for clinical decisions also sits here, with both quoted, because the buyer has to ask which one governs.
Vendor Published

The current pharmacy offering covers prescription processing, refill communication, payer follow up, compliance monitoring and operational support. Exceptions needing clinical judgment go to pharmacists or clinicians, the acceptable use policy keeps decisions with qualified professionals, and no device clearance is claimed for these workflow tools.

Post discharge and chronic care outreach bring the agents closer to patients, and a separate Practice Intelligence Platform with symptom triage is planned for 2027, which would raise its own intended use questions when it launches. Medication reconciliation and administration verification would need their own intended use detail if used beyond operational checking.

CC on AI Governance and Bias DisclosureResponsible artificial intelligence is committed to in policy language with no evaluation behind it. Most of the index sits here.
Vendor Published

Responsible integration, safety and accountability are stated values, and the product supports configurable guardrails and audit records. The company's quality engineering roles call for evaluation sets covering accuracy, hallucination, safety and guardrail adherence, plus regression testing of models and prompts, which describes governance work under way rather than a finished control framework.

No results compare speech recognition, task completion or error handling by language, accent, patient population or pharmacy setting, and no release approval criteria or outside review of model behavior are described. The stated commitment runs ahead of the evidence that it is being carried out.

CC on AI Liability and RecourseMechanisms exist that let someone challenge an output, such as audit trails, source traceability or review before commit, with nothing standing behind the output and no route for the harmed party.
Vendor Published

Action histories and exception routing let pharmacists and clinicians inspect a workflow and challenge an agent's handling before a difficult case closes. The acceptable use policy makes users responsible for reviewing and validating output.

Those mechanisms support correction in operation, but no product accuracy guarantee, indemnity toward the customer or duty to repair harmful output is stated. The website terms carry disclaimers and a liability cap, yet they define the service as the website rather than the agent platform's contract. Patients and other affected parties have only general contact details, an email address and a toll free number, as a route to correction.

Integration and Deployment
BB on EHR and Interoperability DepthNamed systems with read access or one directional writing, or standards support with named deployments behind it.
Vendor Published

Pharmacy integrations are the most specific. DRX, with 400 pharmacies, and Liberty Pharmacy Software, with about 3,000 independent pharmacies, are both labeled live, and an October 2026 outbound workflow description adds structured writeback into DRX with Liberty and Red Sail as extensions of a universal API. Agents also deploy into Epic, Oracle Millennium, athenahealth and smaller EHRs in about four weeks.

Those statements name specific systems and an input and output workflow without a consistent deployment map or interface specification. Pharmacy counts measure potential reach rather than active connections, and two way operation in a named production customer environment is less clear than the stated capability.

CC on Deployment Model and Data ResidencyA single hosted option with location implied rather than committed.
Vendor Published

Agents are configured to work inside existing EHR and pharmacy workflows, with integrations scoped to each engagement and EHR deployment taking about four weeks. Engineering roles center on cloud development across Azure and AWS, but no deployment guide fixes the hosting option or region for voice, model inference and prescription processing.

The Montvale, New Jersey office is an organizational location rather than a data residency commitment, and the website privacy notice permits processing elsewhere without governing the agent platform's data path. Tenant isolation, support access, backup locations and any option to run models inside the customer's own infrastructure are not described.

Commercial
BB on Commercial TransparencyA price or a pricing basis is published without full tiers, so a buyer can size the cost before making contact.
Vendor Published

Pharmacy voice handling is priced as low as $0.10 per minute, or $6 per call hour. A calculator applies that rate to compare estimated AI cost with staff time, with an example of 600 monthly call hours costing $3,600.

That gives a price basis rather than a complete offer, since minimum volumes, telephony charges, implementation fees and eligibility for the lowest rate are not stated. Broader engagements start with one defined workflow and expand across functions through a sales process. No tier table or self service checkout fixes the platform's total cost, and the calculator's projected savings are not a contractual return.

CC on Setting and Specialty CoverageCoverage is claimed broadly without specifics, or stated clearly with nothing validating it yet.
Vendor Published

Independent, retail, specialty and health system pharmacies are the main settings, with patient access workflows also aimed at pharmaceutical manufacturers and the wider platform reaching hospital clinical, administrative and revenue cycle teams. Tasks include refill inquiries, prior authorization follow up, prescription entry, benefits verification, inventory forecasting, diversion monitoring and post discharge outreach, and OncoScope AI runs on the same platform.

Pharmacy system partnerships open a route into those settings without measuring model performance there, and the hospital example remains an unnamed negotiation. Results for recognition accuracy, task completion and safety by specialty are not reported, and the 2027 practice triage product sits outside current coverage.

Alternatives

Alternatives to HendrenAI

Other products that do the same kind of work as HendrenAI, and what each one does.

Magical sells AI agents that do the repetitive operational work in healthcare organizations.

SpinSci sells AI agents for health system patient access.

Cadence Suite helps pharmaceutical manufacturers see where patients are getting stuck between a specialty prescription and ongoing treatment.

Lumistry builds pharmacy communication and operations software. Its Voice AI Assistant, introduced in April 2026, lets callers request refills, check prescription status and get answers about pharmacy hours or location in natural language.

AI voice agents for patient access and revenue cycle calls.

Latent Health sells pharmacy intelligence software that helps health systems get patients onto specialty, infusion and retail medications faster.

Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
Voice handling as low as $0.10 per minute
$0.1 baseline
Pharmacy voice handling starts as low as $0.10 per minute. The wider platform is scoped around an initial workflow and expanded by agreement. Sensitive data use requires a written agreement. No business associate agreement, module coverage or tier restriction is posted. No standard implementation fee, minimum volume or telephony surcharge is listed. EHR deployment takes about four weeks. Vendor Published

The pharmacy cost calculator shows 600 monthly call hours at $3,600 using the advertised rate of $0.10 a minute. It sets no minimum purchase or full subscription price. Eligibility for the lowest rate, included services and charges for agents beyond voice are quoted in a sales discussion. Projected labor savings are estimates rather than guaranteed outcomes.